United States
Germany
Japan
United Kingdom
China
OAS2 mouse monoclonal antibody, clone OTI6E6 (formerly 6E6)
| Applications | IHC, WB |
| Reactivities | Human |
Antibodies
OAS2 mouse monoclonal antibody, clone OTI5E1 (formerly 5E1)
| Applications | IHC, WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI3A3 (formerly 3A3)
| Applications | WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI3C1 (formerly 3C1)
| Applications | WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI5C3 (formerly 5C3)
| Applications | WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI2G3 (formerly 2G3)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) OAS2 mouse monoclonal antibody, clone OTI3A3 (formerly 3A3)
| Applications | WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI4B11 (formerly 4B11)
| Applications | WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI5C10 (formerly 5C10)
| Applications | WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI3D4 (formerly 3D4)
| Applications | WB |
| Reactivities | Human |
OAS2 mouse monoclonal antibody, clone OTI2A1 (formerly 2A1)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) OAS2 mouse monoclonal antibody, clone OTI4B11 (formerly 4B11)
| Applications | WB |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) OAS2 mouse monoclonal antibody, clone OTI5C10 (formerly 5C10)
| Applications | WB |
| Reactivities | Human |
